Published on 6 Oct 2024 on GuruFocus.com · via Yahoo Finance
Applied DNA Sciences Inc (APDN) Q3 2024 Earnings Call Highlights: Navigating...
Total Revenue: $798,000, a decline of $2.1 million from $2.9 million in the prior year.Clinical Laboratory Service Revenue: Decreased by $1.85 million due to the conclusion of the COVID surveillance testing contract.Gross Profit: $245,000 or 31%, down from $1.3 million or 44% in the prior year.Total Operating Expenses: Decreased by $500,000 to $3.6 million from $4.1 million in the prior year.Operating Loss: $3.3 million compared to $2.9 million in the prior year.Adjusted EBITDA: Negative $3.2 million, a decrease of $1.1 million from negative $2.1 million in the prior year.Cash and Cash Equivalents: $10.4 million as of June 30, up from $7.2 million on September 30, 2023.Average Monthly Cash Burn: $1.3 million for the third quarter, up from $500,000 in the prior year.Accounts Receivable: $531,000 as of June 30, with the majority collected after the quarter ended.
Warning! GuruFocus has detected 6 Warning Signs with APDN.